Structural Formula (Doxylamine Succinate And Pyridoxine Hydrochloride 1)
Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release
Product Images NDC 0591-2132
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxylamine Succinate And Pyridoxine Hydrochloride (NDC 0591-2132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula (Doxylamine Succinate And Pyridoxine Hydrochloride 2)
Updated Lbl (Doxylamine Succinate And Pyridoxine Hydrochloride 3)
This is a description of a medication named "Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets". The dosage and instructions on how to use are included. It is warned not to crush or split the tablets. The medication should be kept in a tight and light-resistant container at room temperature. Contact details are provided for healthcare professionals. The manufacturer and distributed by information is also available. A lot/experience number is given along with other codes for reference.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
